Primary Biliary Cirrhosis and the Microbiome

Abstract

Primary biliary cirrhosis is a rather uncommon, slowly progressive, cholestatic liver disease that predominantly affects middle-aged women. Apart from the changes in the gut microbiome that have been described in liver disease in general, little is known of the composition of the microbiome in primary biliary cirrhosis. Nevertheless, epidemiological, clinical, and some experimental evidence points to the possible role of a bacterium (or bacteria) in the initiation of the autoimmune process that leads to the development of this unique clinical phenotype.

Keywords

Primary Biliary Cholangitis - Primary Biliary Cirrhosis - Microbiome - Microbiota - Biliary epithelium - Antimitochondrial antibody

• References

• 1 Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol 2010; 52 (5) 745-758
• 2 Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet 2015; 386 (10003) 1565-1575
• 3 Floreani A, Franceschet I, Cazzagon N. Primary biliary cirrhosis: overlaps with other autoimmune disorders. Semin Liver Dis 2014; 34 (3) 352-360
• 4 Kurtovic J, Riordan SM, Williams R. The natural history of asymptomatic primary biliary cirrhosis. QJM 2005; 98 (5) 331-336
• 5 Imam MH, Lindor KD. The natural history of primary biliary cirrhosis. Semin Liver Dis 2014; 34 (3) 329-333
• 6 Pratt DS. Primary biliary cholangitis--a new name and a new treatment. N Engl J Med 2016; 375 (7) 685-687
• 7 Prince MI, James OF. The epidemiology of primary biliary cirrhosis. Clin Liver Dis 2003; 7 (4) 795-819
• 8 Gross RG, Odin JA. Recent advances in the epidemiology of primary biliary cirrhosis. Clin Liver Dis 2008; 12 (2) 289-303 , viii
• 9 Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012; 56 (5) 1181-1188
• 10 Podda M, Selmi C, Lleo A, Moroni L, Invernizzi P. The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. J Autoimmun 2013; 46: 81-87
• 11 Griffiths L, Dyson JK, Jones DE. The new epidemiology of primary biliary cirrhosis. Semin Liver Dis 2014; 34 (3) 318-328
• 12 Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2012; 12: CD000551
• 13 Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 1997; 17 (1) 13-22
• 14 Parikh-Patel A, Gold E, Mackay IR, Gershwin ME. The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases. Clin Immunol 1999; 91 (2) 206-218
• 15 Kim K-A, Ki M, Choi HY, Kim BH, Jang ES, Jeong S-H. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther 2016; 43 (1) 154-162
• 16 Selmi C, De Santis M, Cavaciocchi F, Gershwin ME. Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis. Dis Markers 2010; 29 (6) 287-299
• 17 Triger DR. Primary biliary cirrhosis: an epidemiological study. BMJ 1980; 281 (6243) 772-775
• 18 Smyk D, Mytilinaiou MG, Rigopoulou EI, Bogdanos DP. PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Dis Markers 2010; 29 (6) 337-344
• 19 Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis 2014; 34 (3) 265-272
• 20 Agmon-Levin N, Katz BS, Shoenfeld Y. Infection and primary biliary cirrhosis. Isr Med Assoc J 2009; 11 (2) 112-115
• 21 Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol 2009; 36 (1) 30-39
• 22 Ortega-Hernandez OD, Levin NA, Altman A, Shoenfeld Y. Infectious agents in the pathogenesis of primary biliary cirrhosis. Dis Markers 2010; 29 (6) 277-286
• 23 Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology 2004; 39 (1) 151-156
• 24 Wang W, Indik S, Wasilenko ST , et al. Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease. Aliment Pharmacol Ther 2015; 41 (4) 393-405
• 25 Morshed SA, Nishioka M, Saito I, Komiyama K, Moro I. Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients. Gastroenterol Jpn 1992; 27 (6) 751-758
• 26 Haruta I, Kikuchi K, Hashimoto E , et al. A possible role of histone-like DNA-binding protein of Streptococcus intermedius in the pathogenesis of bile duct damage in primary biliary cirrhosis. Clin Immunol 2008; 127 (2) 245-251
• 27 Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation?. Hepatology 2001; 33 (3) 530-536
• 28 Mason AL, Farr GH, Xu L, Hubscher SG, Neuberger JM. Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis. Am J Gastroenterol 2004; 99 (12) 2348-2355
• 29 Selmi C, Ross SR, Ansari AA , et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004; 127 (2) 493-501
• 30 Mason AL, Zhang G. Linking human beta retrovirus infection with primary biliary cirrhosis. Gastroenterol Clin Biol 2010; 34 (6–7) 359-366
• 31 Jones DE. A potential retroviral aetiology for mouse PBC: more answers or more questions?. J Hepatol 2011; 55 (4) 750-752
• 32 Bogdanos DP, Baum H, Vergani D, Burroughs AK. The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers 2010; 29 (6) 301-311
• 33 Smyk D, Rigopoulou EI, Zen Y , et al. Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?. World J Gastroenterol 2012; 18 (35) 4855-4865
• 34 Liu HY, Deng AM, Zhang J , et al. Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis. World J Gastroenterol 2005; 11 (26) 4108-4110
• 35 Leung PS, Park O, Matsumura S, Ansari AA, Coppel RL, Gershwin ME. Is there a relation between Chlamydia infection and primary biliary cirrhosis?. Clin Dev Immunol 2003; 10 (2–4) 227-233
• 36 Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?. J Hepatol 2004; 40 (3) 380-384
• 37 Saadah OI, Bokhary RY. Anti-mitochondrial antibody positive autoimmune hepatitis triggered by EBV infection in a young girl. Arab J Gastroenterol 2013; 14 (3) 130-132
• 38 Floreani A, Biagini MR, Zappalà F , et al. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol 1997; 29 (1) 13-17
• 39 Abenavoli L, Arena V, Giancotti F, Vecchio FM, Abenavoli S. Celiac disease, primary biliary cirrhosis and helicobacter pylori infection: one link for three diseases. Int J Immunopathol Pharmacol 2010; 23 (4) 1261-1265
• 40 Feng H, Zhou X, Zhang G. Association between cirrhosis and Helicobacter pylori infection: a meta-analysis. Eur J Gastroenterol Hepatol 2014; 26 (12) 1309-1319
• 41 Durazzo M, Rosina F, Premoli A , et al. Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol 2004; 10 (21) 3179-3181
• 42 Shapira Y, Agmon-Levin N, Renaudineau Y , et al. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden. Exp Mol Pathol 2012; 93 (3) 386-390
• 43 Sakly W, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Dig Dis Sci 2008; 53 (7) 1983-1987
• 44 Yamaguchi H, Miura H, Ohsumi K , et al. Detection and characterization of antibodies to bacterial heat-shock protein 60 in sera of patients with primary biliary cirrhosis. Microbiol Immunol 1994; 38 (6) 483-487
• 45 Stemerowicz R, Möller B, Martin P , et al. Antibody activity against lipopolysaccharides, lipid A and proteins from Enterobacteriaceae in patients with chronic inflammatory liver diseases. Autoimmunity 1990; 7 (4) 305-315
• 46 Bogdanos DP, Baum H, Sharma UC , et al. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol 2002; 36 (1) 14-21
• 47 Miyakawa H, Tanaka A, Selmi C , et al. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Clin Dev Immunol 2006; 13 (2–4) 289-294
• 48 Boomkens SY, de Rave S, Pot RG , et al. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis. FEMS Immunol Med Microbiol 2005; 44 (2) 221-225
• 49 Aron JH, Bowlus CL. The immunobiology of primary sclerosing cholangitis. Semin Immunopathol 2009; 31 (3) 383-397
• 50 Selmi C, Meda F, Kasangian A , et al. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 2010; 7 (1) 1-10
• 51 Wang J, Yang GX, Tsuneyama K, Gershwin ME, Ridgway WM, Leung PS. Animal models of primary biliary cirrhosis. Semin Liver Dis 2014; 34 (3) 285-296
• 52 Verdier J, Luedde T, Sellge G. Biliary mucosal barrier and microbiome. Viszeralmedizin 2015; 31 (3) 156-161
• 53 Haruta I, Kikuchi K, Hashimoto E , et al. Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest 2010; 90 (4) 577-588
• 54 Butler P, Hamilton-Miller J, Baum H, Burroughs AK. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?. Biochem Mol Biol Int 1995; 35 (3) 473-485
• 55 Bogdanos DP, Baum H, Grasso A , et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 2004; 40 (1) 31-39
• 56 Roesler KW, Schmider W, Kist M , et al. Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis. Dig Dis Sci 2003; 48 (3) 561-569
• 57 Stemerowicz R, Hopf U, Möller B , et al. Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of Enterobacteriaceae?. Lancet 1988; 2 (8621) 1166-1170
• 58 Hopf U, Möller B, Stemerowicz R , et al. Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989; 2 (8677) 1419-1422
• 59 Fussey SP, Ali ST, Guest JR, James OF, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A 1990; 87 (10) 3987-3991
• 60 Vilagut L, Parés A, Viñas O, Vila J, Jiménez de Anta MT, Rodés J. Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur J Clin Invest 1997; 27 (8) 667-672
• 61 Bogdanos DP, Pares A, Baum H , et al. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun 2004; 22 (4) 353-362
• 62 Berg CP, Kannan TR, Klein R , et al. Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int 2009; 29 (6) 797-809
• 63 Bogdanos DP, Baum H, Okamoto M , et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 2005; 42 (2) 458-465
• 64 Bogdanos D, Pusl T, Rust C, Vergani D, Beuers U. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol 2008; 49 (3) 466-473
• 65 Bogdanos DP, Baum H, Gunsar F , et al. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol 2004; 39 (10) 981-987
• 66 Olafsson S, Gudjonsson H, Selmi C , et al. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol 2004; 99 (11) 2143-2146
• 67 Kaplan MM. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol 2004; 99 (11) 2147-2149
• 68 Padgett KA, Selmi C, Kenny TP , et al. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J Autoimmun 2005; 24 (3) 209-219
• 69 Tanimoto H, Shimoda S, Nakamura M , et al. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. J Autoimmun 2003; 20 (3) 255-263
• 70 Mattner J, Savage PB, Leung P , et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008; 3 (5) 304-315
• 71 Morita S, Joshita S, Umemura T , et al. Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis. Hum Immunol 2013; 74 (2) 219-222
• 72 Haruta I, Hashimoto E, Kato Y , et al. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis. Autoimmunity 2006; 39 (2) 129-135
• 73 Tsuneyama K, Harada K, Kono N , et al. Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis. J Hepatol 2001; 35 (2) 156-163
• 74 Palmer JM, Jones DE, Quinn J, McHugh A, Yeaman SJ. Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 1999; 30 (1) 21-26
• 75 Dubel L, Tanaka A, Leung PS , et al. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 1999; 29 (4) 1013-1018
• 76 Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007; 28 (2–3) 76-84
• 77 Selmi C, Balkwill DL, Invernizzi P , et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38 (5) 1250-1257
• 78 Haruta I, Hashimoto E, Shibata N, Kato Y, Kobayashi M, Shiratori K. Lipoteichoic acid may affect the pathogenesis of PBC-like bile duct damage and might be involved in systemic multifocal epithelial inflammations in chronic colitis-harboring TCRalpha-/-xAIM-/- mice. Autoimmunity 2007; 40 (5) 372-379
• 79 Yanagisawa N, Haruta I, Kikuchi K, Shibata N, Yagi J. Are dysregulated inflammatory responses to commensal bacteria involved in the pathogenesis of hepatobiliary-pancreatic autoimmune disease? An analysis using mice models of primary biliary cirrhosis and autoimmune pancreatitis. ISRN Gastroenterol 2011; 2011: 513514
• 80 Haruta I, Kikuchi K, Nakamura M , et al. Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis. J Clin Immunol 2012; 32 (5) 1026-1037
• 81 Wang JJ, Yang GX, Zhang WC , et al. Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice. Clin Exp Immunol 2014; 175 (2) 192-201
• 82 Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010; 7 (12) 691-701
• 83 Quigley EM, Monsour HP. The gut microbiota and the liver: implications for clinical practice. Expert Rev Gastroenterol Hepatol 2013; 7 (8) 723-732
• 84 Chen Y, Yang F, Lu H , et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011; 54 (2) 562-572
• 85 Qin N, Yang F, Li A , et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513 (7516) 59-64
• 86 Yoshimoto S, Loo TM, Atarashi K , et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499 (7456) 97-101
• 87 Tomiyama Y, Takenaka K, Kodama T , et al. Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis. Intern Med 2013; 52 (14) 1553-1559
• 88 Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology 2012; 56 (4) 1409-1417
• 89 Iqbal S, Quigley EM. Progress in our understanding of the gut microbiome: implications for the clinician. Curr Gastroenterol Rep 2016; 18 (9) 49
• 90 Lv LX, Fang DQ, Shi D , et al. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis. Environ Microbiol 2016; 18 (7) 2272-2286